Cumulative incidence of and predictive factors for lung cancer in IPF

…, T Fujisawa, Y Nakamura, N Inui, H Nakamura… - …, 2009 - Wiley Online Library
Background and objective: Previous studies have indicated a high incidence of lung cancer
in IPF, and some have identified its risk factors. However, those studies were retrospective …

Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer

…, D Hahimoto, Y Nakamura, N Inui, H Nakamura… - Lung cancer, 2010 - Elsevier
BACKGROUND: Indoleamine 2,3-dioxygenase (IDO) catalyzes the rate-limiting step of
tryptophan (Trp) degradation along the kynurenine (Kyn) pathway. By depleting tryptophan, IDO …

[HTML][HTML] Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases

T Suda, Y Kaida, Y Nakamura, N Enomoto… - Respiratory …, 2009 - Elsevier
BACKGROUND: Acute exacerbation (AE) is currently established as a distinct condition
with acute deterioration of respiratory status in idiopathic pulmonary fibrosis (IPF). Recently, …

Higher Sensitivity and Specificity for Diffusion-weighted Imaging of Malignant Lung Lesions without Apparent Diffusion Coefficient Quantification1

T Uto, Y Takehara, Y Nakamura, T Naito, D Hashimoto… - Radiology, 2009 - pubs.rsna.org
Purpose: To compare the performance of apparent diffusion coefficient (ADC) with that of
signal intensity of the lesion-to–spinal cord ratio (LSR) in differentiating lung cancer from …

Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.

T Fujisawa, T Suda, Y Nakamura, N Enomoto… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To assess the difference in clinical features and prognosis of patients with
interstitial lung disease (ILD) comparing polymyositis (PM) and dermatomyositis (DM). METHODS…

[HTML][HTML] Prognostic factors for myositis-associated interstitial lung disease

…, M Kono, N Enomoto, D Hashimoto, Y Nakamura… - PLoS one, 2014 - journals.plos.org
Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …

Interstitial lung diseases associated with amyopathic dermatomyositis

…, T Fujisawa, N Enomoto, Y Nakamura… - European …, 2006 - Eur Respiratory Soc
The aim of the present study was to clarify the clinical characteristics and prognosis of
patients with interstitial lung disease (ILD) associated with amyopathic dermatomyositis (ILD-ADM)…

[HTML][HTML] Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease

…, A Murakami, N Enomoto, N Inui, Y Nakamura… - Respiratory …, 2016 - Elsevier
Objectives Myositis-specific autoantibodies (MSAs) are associated with clinical phenotypes
in polymyositis/dermatomyositis (PM/DM). No study has investigated the clinical features …

Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study

H Hozumi, Y Nakamura, T Johkoh, H Sumikawa… - BMJ open, 2013 - bmjopen.bmj.com
Objectives To investigate the risk factors and prognosis associated with acute exacerbation (AE)
in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). …

[HTML][HTML] Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis

K Furuhashi, T Suda, Y Nakamura, N Inui… - Respiratory …, 2010 - Elsevier
BACKGROUND: YKL-40, a mammalian member of chitinase-like proteins, has been shown
to play a role in pathological conditions leading to tissue remodeling and fibrosis. Recently, …